Global expansion H&T Presspart combines in-house manufacturing with a recent strategic acquisition of Plas-Tech Engineering, expanding capabilities for parenteral markets, small-batch and low-volume projects, and Equinox prefillable syringes, creating cross-border sales opportunities across Europe, the USA, and beyond.

Parenteral focus The addition of Plas-Tech’s Equinox portfolio and emphasis on parenteral solutions positions the company to target biologics and high-viscosity formulations, suggesting upsell potential for premium drug delivery devices and customized syringes with compatible accessories.

End-to-end support With services spanning concept to manufacturing at scale and a multi-site footprint (Germany, Spain, Switzerland, USA, UK) plus sales representation in China, India, and Uruguay, there are multi-regional opportunities to bundle device components, prototyping, tooling, and manufacturing services for new drug-device programs.

Industry engagement Regular participation in major conferences and events (CPhI China, BIO, RDD, SMIs) signals active outreach and visibility; leverage is available to position as a partner for customers seeking regulatory-ready, innovative delivery solutions in respiratory and biologic therapies.

Growth signals Investments in manufacturing technology (new wash plant in Blackburn) and a revenue profile in the low to mid millions indicate scalability potential; target mid-market pharma and contract development manufacturers seeking reliable supply of prefillable and device components at variable volumes.